FierceBiotech Jan 9, 2026 Roche returns to MediLink with promise of $570M near-term payments for another ADC
Endpoints News Jan 9, 2026 Gene editing pioneers launch first startup focused on custom CRISPR therapies
BioPharma Dive Jan 9, 2026 Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies
Roche Media Jan 9, 2026 Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
Agilent Jan 9, 2026 Robeco Institutional Asset Management B.V. Acquires 26,573 Shares of Agilent Technologies, Inc. $A - MarketBeat
Thermo Fisher Jan 9, 2026 Stifel raises Thermo Fisher Scientific stock price target to $700 on biopharma growth outlook - Investing.com
Thermo Fisher Jan 9, 2026 Stifel raises Thermo Fisher Scientific stock price target to $700 on biopharma growth outlook - Investing.com India
Illumina Jan 9, 2026 Illumina hires former NHGRI director Eric Green as new chief medical officer - Fierce Biotech
Brady Corporation Jan 9, 2026 Is Brady Corporation's (NYSE:BRC) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Yahoo Finance
Pharmaron Jan 9, 2026 Building a comprehensive analytical toolbox for mAb CQA assessment - News-Medical
Agilent Jan 9, 2026 Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com
Agilent Jan 9, 2026 Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com
Illumina Jan 9, 2026 Illumina and PREMIA partner to expand clinical access to CGP in Asia - TheWire.in
Waters Jan 9, 2026 Why Waters Corporation stock remains on buy lists - Chart Signals & Low Risk Entry Point Tips - ulpravda.ru
Endpoints News Jan 9, 2026 Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals